SSIA
BIIB icon

Spero-Smith Investment Advisers’s Biogen BIIB Stock Holding History

Spero-Smith Investment Advisers’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-5,516
Closed -$2.23M – 44
2015
Q2 		$2.23M Sell
5,516
-90
-2% -$36.1K 2.53% 16
2015
Q1 		$2.37M Buy
+5,606
New +$2.21M 2.63% 14

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Spero-Smith Investment Advisers's BIIB Position: Q3 2015 in Review

Spero-Smith Investment Advisers sold out of Biogen (BIIB) in Q3 2015, closing a stake of 5,516 shares — an estimated $2.23M sold.

Spero-Smith Investment Advisers first reported a position in BIIB in Q1 2015 and held it in 2 quarters. The position peaked at $2.37M in Q1 2015. 924 funds tracked by Wall St. Rank hold BIIB as of Q3 2015.

  • Spero-Smith Investment Advisers reported no remaining Biogen position as of Q3 2015 after selling out during the quarter.
  • Spero-Smith Investment Advisers sold 5,516 Biogen shares in Q3 2015, an estimated $2.23M.
  • Spero-Smith Investment Advisers first reported a position in Biogen in Q1 2015 and held it in 2 quarters.
  • Spero-Smith Investment Advisers's Biogen position peaked at $2.37M in Q1 2015.
  • 924 funds tracked by Wall St. Rank held Biogen as of Q3 2015.

Based on Spero-Smith Investment Advisers's 13F filing for Q3 2015, filed 12 Nov 2015.